|
|
|
|
| Symbol(s): |
PPCO |
| Date: |
7-Feb-10 |
| Contributor: |
PriceTarget Research, Inc. |
| Title: |
PPCO has a current Overall Rating of B (Positive). |
| Document Size: |
7 pages |
| Price: |
$25 |
| Document Type: |
Adobe Acrobat Reader®
Download free Adobe Acrobat Reader® |
|
| Research Reports Premium Services |
| ·
|
Get the full report for $25. |
| ·
|
You will have access to this report for 24 hours. |
|
|
|
|
|
| PPCO has a current Overall Rating of B (Positive). Appreciation potential (93) is very high; Power Rating (32) is low. Relative to the S&P 500 Composite, Penwest Pharmaceuticals Co has moderate Value characteristics -- its appeal is likely to be to Capital Gain-oriented investors. PPCO is of very low investment quality. PPCO's current technical position is very strong. PPCO's Power Rating is 32. However, earnings estimate behavior for PPCO has been slightly favorable recently. PPCO's...
| | |
|
|
